P
Parikshit S. Sharma
Researcher at Rush University Medical Center
Publications - 121
Citations - 3453
Parikshit S. Sharma is an academic researcher from Rush University Medical Center. The author has contributed to research in topics: Medicine & Cardiac resynchronization therapy. The author has an hindex of 22, co-authored 93 publications receiving 2013 citations. Previous affiliations of Parikshit S. Sharma include Geisinger Health System & Virginia Commonwealth University.
Papers
More filters
Journal ArticleDOI
Low Fluoroscopy Permanent His Bundle Pacing Using Electroanatomic Mapping: A Feasibility Study.
Parikshit S. Sharma,Henry D. Huang,Richard G. Trohman,Angela Naperkowski,Kenneth A. Ellenbogen,Pugazhendhi Vijayaraman +5 more
TL;DR: Electroanatomic mapping-guided PHBP is feasible can be performed safely and results in a significant reduction in fluoroscopy duration and exposure.
Journal ArticleDOI
Electrophysiological characteristics and clinical values of left bundle branch current of injury in left bundle branch pacing.
Lan Su,Tiancheng Xu,Mengxing Cai,Lei Xu,Pugazhendhi Vijayaraman,Parikshit S. Sharma,Xiao Chen,Rujie Zheng,Shengjie Wu,Weijian Huang +9 more
TL;DR: Left bundle branch pacing (LBBP) is emerging as a novel option for physiological ventricular pacing and the impact of current of injury at left bundle branch has not been previously evaluated.
Journal ArticleDOI
Permanent His Bundle Pacing: The Past, Present, and Future.
TL;DR: The anatomy and physiology of the HB, the available data on permanent HB pacing, its current and potential future applications, and more data on the feasibility and advantages of pacing at the His Bundle region are reviewed.
Journal ArticleDOI
Amiodarone and thyroid physiology, pathophysiology, diagnosis and management.
TL;DR: The purpose of this review is to provide a comprehensive "bench to bedside" overview of the ways amiodarone influences thyroid function, and to identify peer-reviewed clinical trials, randomized controlled trials, meta-analyses, and other clinically relevant studies.
Journal ArticleDOI
Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
Kenneth A. Ellenbogen,Jayanthi N. Koneru,Parikshit S. Sharma,Sanjay Deshpande,Chingping Wan,Steven J. Szymkiewicz +5 more
TL;DR: Clinicians may use the WCD as an ICD alternative when reimplantation is medically delayed, and WCD demonstrated a high efficacy for protecting patients from VT/VF.